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Cg glioma cells were stimulated with the /3-adrenergic agonist isoproterenol. The rate of cyclic AMP 
accumulation and lipid methylation increased. However, the elevated rate of lipid methylation did not 
affect the fluidity of the plasma membrane. It is concluded that lipid methylation is not responsible for 
making the plasma membrane more fluid during the @-adrenergic response. 
Lipid methylation 
1. INTRODUCTION 
An increased rate of conversion of 
phosphatidylethanolamine to phosphatidylcholine 
is associated with a variety of events that are 
mediated by the plasma membranes of intact cells 
[ 1,2]. The role of phospholipid N-methylation re- 
mains obscure although it has been suggested that 
the enhanced rate of phosphatidylcholine biosyn- 
thesis from phosphatidylethanolamine which ac- 
companies fi-adrenergic stimulation might make 
the plasma membrane more fluid thereby 
facilitating coupling between the ,8-adrenergic 
receptor and adenylate cyclase [l]. Authors in [3] 
have disputed a link between increases in flux 
through the methylation pathway and increased 
fluidity, primarily on theoretical grounds. We 
report here that stimulation of lipid methylation 
and cyclic AMP accumulation in intact C6 
astrocytoma cells by isoproterenol is not accom- 
panied by any change in the molecular order of 
plasma membrane lipid. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
C6 astrocytoma cells were grown until confluent 
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in Dulbecco’s Eagle’s Medium supplemented with 
5% foetal calf serum, penicillin (100 III/ml) and 
streptomycin (lOOpg/ml) (all from Flow 
Laboratories) in an atmosphere of 5% carbon 
dioxide, 95% air at 37°C. 
2.2. Lipid methylation 
Cells were grown in Linbro multi-dish trays 
(OS-o.7 mg protein per well). After the cells had 
been incubated at 37°C with 20 &i 
[methyl-3H]methionine in 1 ml Medium 199 (Flow 
Laboratories) for 25 min, the drugs were added 
and the incubations were continued for a further 
30 min. Lipids were extracted from the cells with 
chloroform/methanol exactly as in [4]. In each 
6-well Linbro tray, 4 wells were used for measuring 
the uptake of [3H]methyl groups into lipid and the 
remaining two wells were used to determine the 
protein content of the cells. The results are express- 
ed as pmol [3H]methyl groups incorporated into 
lipid/55 min incubation period per mg protein. 
2.3. Cyclic AMP measurement 
Cells were grown in Petri dishes (4.5 cm 
diameter, 0.9-1.1 mg protein) and their cyclic 
AMP content was measured after the same periods 
of incubation in the presence of Medium 199 
(3 ml) and drugs as used in the methylation ex- 
periments. Incubations were stopped by washing 
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the cells with ice-cold saline (pH 7.4) and cyclic 
AMP was extracted with 0.1 M HCI (1 ml). After 
30 min the acid extract was removed and its cyclic 
AMP content was measured by a protein-binding 
method [5]. The protein content of the cellular 
residue was measured as in [6]. 
2.4. Electron spin resonance 
The cells were grown in Petri dishes (9 cm 
diameter, 1.6-2.0 mg protein) and the incubation 
protocol was similar to that described for the 
methylation and cyclic AMP experiments. Cells 
were incubated in Medium 199 (10 ml) for 25 min 
and incubated for a further 30 min in the presence 
of drugs. Ten minutes before the end of the in- 
cubation in the presence of the drugs, 3 /rl of an 
ethanolic solution of 5-doxylstearic acid 
(5-(4 ’ ,4 ’ -dimethyloxazolidine-N-oxyl)stearic acid) 
(5Opg, Syva) were added. Cells were harvested by 
scraping with a rubber policeman, centrifuged at 
1000 rpm for 5 min and then transferred to a 
capillary for the electron spin resonance (ESR) 
measurements. Spectra were recorded with a Jeol 
JES-PE-1X spectrometer equipped with a 
temperature control system. To minimize inter- 
nalization and destruction of the spin-labelled fat- 
ty acid, spectra were recorded at 30°C. There was 
no significant contribution to the spectra from 
unincorporated label and repeat scans on the same 
sample showed little diminution in signal intensity 
over a 15 min period. The molecular order of the 
spin-labelled fatty acid was assessed by measuring 
the hyperfine splitting of the outer extrema of the 
ESR spectra [7,8]. 
3. RESULTS AND DISCUSSION 
We have measured here changes in the physical 
properties of plasma membrane lipid in intact C6 
cells by studying the motional properties of a spin- 
label probe. 5-Doxylstearic acid partitions into the 
plasma membranes of cultured cells and remains 
there for at least 30 min [9]. Recent studies on Sar- 
coma 180 cells have shown that changes in the 
ordering of 5-doxylstearic acid in the plasma mem- 
brane are a sensitive indicator of the interaction of 
certain drugs with the cell surface [lo]. The ESR 
spectrum of 5-doxylstearic acid in biological mem- 
branes is characteristic of anisotropic motion 
about the bilayer normal and the degree of 
anisotropy is a measure of the average amplitude 
of motion of the spin label about the long axis of 
the fatty acid chain. The smaller the angular mo- 
tion, the more anisotropic is the derived spectrum 
and the membrane lipid is therefore more ordered. 
The extent of the lipid ordering is one measure of 
membrane fluidity [7]. We have measured the 
order of 5-doxylstearic acid in the plasma mem- 
branes of intact C6 aStrOCytOma CdlS by measuring 
the hyperfine splitting (2T’ $1 of the outer ex- 
trema of ESR spectra. The larger the splitting, the 
more ordered, i.e., the less fluid is the membrane. 
This measurement is a very sensitive indicator of 
changes in the order of membrane lipid [8]. 
Table 1 shows that incubation of C6 cells with 
the ,&adrenergic agonist isoproterenol causes an 
Table 1 
Effects of isoproterenol and propranolol on lipid methylation, cyclic AMP accumulation and the physical properties 
of plasma membranes in intact Ca cells 
Drug (3H]Methyl incorporated Cyclic AMP 2T’, (G)’ 
into lipid (pmol/mg protein)b 
(pmol/mg protein) 
None 
Isoproterenol (10 PM) 
Isoproterenol (10 ,uM) + 
propranolol (500 PM) 
Propranolol (500 ,uM) 
32+ 4 14* 3 52.9 f 0.1 
75 f 10 806 f 133 52.9 f 0.1 
36+ 5 27zt 5 53.7 f 0.1 
35 * 11 13* 1 53.9 f 0.1 
a Means of 4 assays f SE 
b Means of 3 assays +. SE 
’ Means of measurements from the spectra of 4 different samples f SD 
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intracellular accumulation of cyclic AMP and that 
this is accompanied by a stimulation in the rate of 
lipid methylation. Furthermore, propranolol 
blocks these responses which demonstrates that 
both effects are mediated by the P-adrenergic 
system. These results are consistent with those in 
[2]. If the increased rate of lipid methylation were 
to affect the physical properties of plasma mem- 
brane lipid, a change in the hyperfine splitting of 
the ESR spectrum of 5-doxylstearic acid should 
have been detected: that this is not the case is 
shown in table 1. Therefore it seems unlikely that 
lipid methylation influences fl-adrenergic activa- 
tion of the adenylate cyclase in Cg cells by altering 
the motional properties of lipid in the plasma 
membrane. Table 1 also shows that, by contrast, 
propranolol does affect the physical properties of 
plasma membrane lipid. Propranolol has been 
shown to increase the order of pure phospholipid 
bilayers [l l] and it clearly has a similar effect on 
the pkiSnX3 membrane of C6 Cells. 
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